News
2022
August 1, 2022
Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
VIEW PRESS RELEASEJuly 18, 2022
Brookline Capital Markets Hosts Biotech Symposium Today
VIEW PRESS RELEASEJune 9, 2022
Brookline Capital Markets Announces Strategic Partnership Agreement with Stuart Frankel & Co.
VIEW PRESS RELEASEJune 7, 2022
AnaBios Closes Financing with Ampersand Capital Partners
VIEW PRESS RELEASEJune 6, 2022
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
VIEW PRESS RELEASE2021
December 21, 2021
Larkspur Health Acquisition Corp. Prices $75 Million Initial Public Offering
VIEW PRESS RELEASEDecember 15, 2021
Ault Disruptive Technologies Corporation Prices $100 Million Initial Public Offering
VIEW PRESS RELEASEDecember 13, 2021
IceCure Medical LTD. Closes $17 Million Underwritten Public Offering
VIEW PRESS RELEASEDecember 13, 2021
Alpha Star Acquisition Prices $100M IPO
VIEW PRESS RELEASEDecember 08, 2021
Inception Growth Acquisition Limited Announces Pricing of $90,000,000 Initial Public Offering
VIEW PRESS RELEASE2020
October 29, 2020
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
VIEW PRESS RELEASESeptember 11, 2020
Creatd, Inc., Formerly Jerrick Media Holdings, Inc., Announces Pricing of $7,762,500 Public Offering
VIEW PRESS RELEASEAugust 27, 2020
Nuveen Dynamic Municipal Opportunities Fund Attracts $780.0 Million
VIEW PRESS RELEASEAugust 22, 2020
CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEAugust 10, 2020
NervGen Pharma Corp. Completes $6.45 Million Public Offering
VIEW PRESS RELEASE2019
December 23, 2019
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
VIEW PRESS RELEASEDecember 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 22, 2019
Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
VIEW PRESS RELEASESeptember 26, 2019
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
VIEW PRESS RELEASEAugust 6, 2019
BioCardia Announces Closing of $10.0 Million Public Offering
VIEW PRESS RELEASE
